ClinicalTrials.govpublic full text
Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM)
lung cancer, breast cancer, prostate cancer, tumors (others), ovarian cancer, immune response, maximum tolerated dose, vaccine therapy, increased expression of brachyury, immunotherapy, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 852205
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.